Pavmed Inc (PAVM):企業の製品パイプライン分析2018

◆英語タイトル:Pavmed Inc (PAVM) - Product Pipeline Analysis, 2018 Update
◆商品コード:DATA904C12748
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pavmed Inc (Pavmed) is a medical device company. The company offers disposable infusion pumps, short-term catheters, percutaneous and tissue ablation devices, and long-term vascular access devices. Its products pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; PortIO, an implantable intraosseous vascular access device; and DisappEAR, an antimicrobial resorbable ear tube. Pavmed’s product pipeline also comprises NextCath, a self-anchoring catheter; NextFlo, a disposable infusion system; and Caldus, a disposable tissue ablation device. The company has operations throughout the US. Pavmed is headquartered in New York, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Pavmed Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Pavmed Inc Company Overview 4
Pavmed Inc Company Snapshot 4
Pavmed Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Pavmed Inc – Pipeline Analysis Overview 7
Pavmed Inc – Key Facts 7
Pavmed Inc – Major Products and Services 8
Pavmed Inc Pipeline Products by Development Stage 9
Pavmed Inc Pipeline Products Overview 11
Caldus – Renal Denervation 11
Caldus – Renal Denervation Product Overview 11
Caldus – Traditional Tissue Ablation 12
Caldus – Traditional Tissue Ablation Product Overview 12
CarpX 13
CarpX Product Overview 13
DisappEAR 14
DisappEAR Product Overview 14
NextCath 15
NextCath Product Overview 15
NextFlo 16
NextFlo Product Overview 16
PortIO 17
PortIO Product Overview 17
PortIO Device – Next Generation 18
PortIO Device – Next Generation Product Overview 18
Pavmed Inc – Key Competitors 19
Pavmed Inc – Key Employees 20
Pavmed Inc – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Pavmed Inc, Recent Developments 22
Jul 11, 2018: PAVmed Appoints Shaun O’Neil Chief Commercial Officer 22
Jul 09, 2018: Nasdaq Notifies PAVmed of Regained Compliance with Continued Listing Requirements 22
Jun 27, 2018: PAVmed Provides Business Update 23
May 22, 2018: PAVmed Announces First Quarter 2018 Financial Results 24
Dec 18, 2017: Fierce Innovation Awards 2017 Recognizes PAVmeds CarpX Device for Technology Innovation 25
Nov 28, 2017: Pavmed Files 510(K) Submission With FDA for Carpx Device to Treat Carpal Tunnel Syndrome 26
Nov 15, 2017: PAVmed Reports Third Quarter 2017 Financial Results 27
Aug 14, 2017: PAVmed Reports Second Quarter 2017 Financial Results 28
May 22, 2017: PAVmed Reports First Quarter 2017 Financial Results and Provides Business Update 29
May 10, 2017: PAVmed to Hold Business Update Conference Call on May 17th 30
Appendix 31
Methodology 31
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Pavmed Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Pavmed Inc Pipeline Products by Equipment Type 5
Pavmed Inc Pipeline Products by Indication 6
Pavmed Inc, Key Facts 7
Pavmed Inc, Major Products and Services 8
Pavmed Inc Number of Pipeline Products by Development Stage 9
Pavmed Inc Pipeline Products Summary by Development Stage 10
Caldus - Renal Denervation - Product Status 11
Caldus - Renal Denervation - Product Description 11
Caldus - Traditional Tissue Ablation - Product Status 12
Caldus - Traditional Tissue Ablation - Product Description 12
CarpX - Product Status 13
CarpX - Product Description 13
DisappEAR - Product Status 14
DisappEAR - Product Description 14
NextCath - Product Status 15
NextCath - Product Description 15
NextFlo - Product Status 16
NextFlo - Product Description 16
PortIO - Product Status 17
PortIO - Product Description 17
PortIO Device - Next Generation - Product Status 18
PortIO Device - Next Generation - Product Description 18
Pavmed Inc, Key Employees 20
Glossary 33

List of Figures
Pavmed Inc Pipeline Products by Equipment Type 5
Pavmed Inc Pipeline Products by Development Stage 9

★海外企業調査レポート[Pavmed Inc (PAVM):企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Thomas Cook Group plc:企業の戦略・SWOT・財務情報
    Thomas Cook Group plc - Strategy, SWOT and Corporate Finance Report Summary Thomas Cook Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Beactica AB-製薬・医療分野:企業M&A・提携分析
    Summary Beactica AB (Beactica) is a drug discovery company that focuses on the development of novel therapeutics. The company offers wide range of services such as fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis and antibody interaction …
  • Kotak Mahindra Bank Ltd (KOTAKBANK):企業の財務・戦略的SWOT分析
    Kotak Mahindra Bank Ltd (KOTAKBANK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • CoreRx Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CoreRx Inc (CoreRx) is a contract development manufacturing organization that provides a comprehensive range of drug development services. The company provides products portfolio such as oral, topical, liquids or parental, ophthalmic and combined medicines, among others. It provides a wide r …
  • BHG SA – Brazil Hospitality Group:企業の戦略・SWOT・財務分析
    BHG SA - Brazil Hospitality Group - Strategy, SWOT and Corporate Finance Report Summary BHG SA - Brazil Hospitality Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • PrIME Biologics Pte Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary PrIME Biologics Pte Ltd (PrIME Biologics) is a biotechnology company that develops and manufactures plasma products for human use. The company uses Preparative Isolation by Membrane Electrophoresis ((PrIME) technology, a disposable, fully-scalable and modular manufacturing process, to manufa …
  • Southwest Gas Holdings, Inc.:企業の戦略・SWOT・財務分析
    Southwest Gas Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Southwest Gas Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Recurrent Energy LLC:電力:M&Aディール及び事業提携情報
    Summary Recurrent Energy LLC (Recurrent Energy), a subsidiary of Canadian Solar Inc. is a mainstream clean energy company that operates a portfolio of solar energy projects and generates electricity. The company develops and operates a portfolio of utility scale power projects. It has more than 4 GW …
  • Artisan Partners Asset Management Inc.:企業の戦略・SWOT・財務情報
    Artisan Partners Asset Management Inc. - Strategy, SWOT and Corporate Finance Report Summary Artisan Partners Asset Management Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Vaccitech Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Vaccitech Ltd (Vaccitech) is a clinical stage company that focuses on the development of universal flu vaccines. The company is developing clinical programs for the treatment of influenza, prostate cancer, HBV, Middle East respiratory syndrome (MERS), shingles, human papillomavirus (HPV), an …
  • Blue Label Telecoms Ltd (BLU):企業の財務・戦略的SWOT分析
    Blue Label Telecoms Ltd (BLU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • NewYork-Presbyterian Hospital:企業の戦略的SWOT分析
    NewYork-Presbyterian Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Photronics Inc (PLAB):企業の財務・戦略的SWOT分析
    Summary Photronics Inc (Photronics) is a manufacturer of semiconductor photomasks. The company’s products include mature binary, advanced binary reticles, embedded attenuated phase shift masks, large area masks for flat panel displays, high transmission embedded attenuated phase shift masks, alterna …
  • Fugro NV (FUR):石油・ガス:M&Aディール及び事業提携情報
    Summary Fugro NV (Fugro) is an integrated provider of geotechnical, survey, subsea and geosciences services. The company specializes in earth and engineering data services, from project preparation through to data acquisition, processing, analysis and interpretation, reporting and consulting. It ass …
  • Telekom Malaysia Berhad (TM):企業の財務・戦略的SWOT分析
    Telekom Malaysia Berhad (TM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Tourism Holdings Limited:企業の戦略・SWOT・財務分析
    Tourism Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Tourism Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Centene Corporation:企業の戦略・SWOT・財務情報
    Centene Corporation - Strategy, SWOT and Corporate Finance Report Summary Centene Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • CK Infrastructure Holdings Ltd (1038):石油・ガス:M&Aディール及び事業提携情報
    Summary CK Infrastructure Holdings Limited (CKI), a subsidiary of CK Hutchison Holdings Limited, is an infrastructure investment company. It holds diversified investment interests across various sectors including energy, rail transportation, water, waste management, and other infrastructure related …
  • MDU Resources Group, Inc.:企業の戦略・SWOT・財務情報
    MDU Resources Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary MDU Resources Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Ipsos SA (IPS):企業の財務・戦略的SWOT分析
    Ipsos SA (IPS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆